PAC-1-d8 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Labelled PAC-1 is a caspase 3 activator. Caspase activation is a key strategy in cancer therapy. Caspase 3 is a key executioner caspase and direct effector of apoptosis. Hallmark of many cancers is the circumvention of signal in the activation of executioner caspases and loss of apoptotic response. EC50 for caspase 3 activation = 0.33 μM and caspase 7= 4.5 μM. The IC50 for apoptosis induction = 0.92 μM. Elevated caspase 3 level in cancerous cell lines and tissues allows PAC-1 to selectively induce apoptosis in tissues.

PAC-1-d8 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

PAC-1-d8 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
J & K SCIENTIFIC LTD.	010-82848833 400-666-7788	jkinfo@jkchemical.com	China	96815	76
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32321	50
Shanghai TaoSu Biochemical Technology Co., Ltd.	021-33632979	info@tsbiochem.com	China	8065	58
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 +86-13028896684;	sales@rrkchem.com	China	57423	58
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44807	58

---

• PAC-1-d8
• YQNRVGJCPCNMKT-SRNXAORYSA-N
• [2H8]-PAC-1
• 1287241-26-2
• C23H20D8N4O2
• Aromatics, Heterocycles, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals
• Aromatics
• Heterocycles
• Intermediates & Fine Chemicals
• Isotope Labelled Compounds
• Pharmaceuticals